Paracetamol and Ibuprofen With or Without Famotidine for Calcific Tendinitis of the Shoulder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Dubrava

About this trial

This randomized, open-label, single-centre controlled study evaluates the efficacy and safety of combined paracetamol and ibuprofen therapy with versus without famotidine in the treatment of calcific tendinitis of the shoulder. Outcomes include pain reduction, functional improvement, radiological changes, and need for additional interventions over a 12-month follow-up period.

Eligibility criteria

Qualifiers

Age ≥18 years

Clinical history of shoulder pain consistent with calcific tendinitis

Presence of calcifications confirmed by shoulder X-ray

Ability and willingness to comply with study procedures and follow-up

Disqualifiers

Known allergy or hypersensitivity to paracetamol, ibuprofen, or famotidine

Active gastrointestinal disease contraindicating NSAID use

Chronic dual antiplatelet therapy

Current use of proton pump inhibitors other than pantoprazole (unless temporarily replaced)

Trial design

Treatments tested in this trial

  • Paracetamol + Ibuprofen + Famotidine
  • Paracetamol + Ibuprofen

Treatment groups

200 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators